SEC Form 4 · accession 0001140361-15-010832
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Henry Ward Wolff
Officer — Exec VP & CFO
Period of report
Mar 4, 2015
Accepted (ET)
Mar 6, 2015 · 7:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 4, 2015 | M | 10,000 | $14.27 | A | 216,849 | D | |
| Common StockF1 | Mar 4, 2015 | S | 10,000 | $18.00 | D | 206,849 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $14.27 | Mar 4, 2015 | M | 10,000 | A | — | Dec 2, 2017 | Common Stock | 10,000 | 261,972 | D |
Explanation of responses
- F1Includes 15,000, 23,333 and 37,500 shares subject to RSUs granted on December 6, 2012, December 12, 2013 and December 11, 2014 respectively, that will be issued as such units vest in accordance with their terms.
- F2All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2014, as amended.
- F3All shares underlying these options are vested and exercisable immediately.